Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Neurovascular abnormalities in humans and mice with Huntington's disease.

Lin CY, Hsu YH, Lin MH, Yang TH, Chen HM, Chen YC, Hsiao HY, Chen CC, Chern Y, Chang C.

Exp Neurol. 2013 Dec;250:20-30. doi: 10.1016/j.expneurol.2013.08.019. Epub 2013 Sep 10.

PMID:
24036415
2.

Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology.

Drouin-Ouellet J, Sawiak SJ, Cisbani G, Lagacé M, Kuan WL, Saint-Pierre M, Dury RJ, Alata W, St-Amour I, Mason SL, Calon F, Lacroix S, Gowland PA, Francis ST, Barker RA, Cicchetti F.

Ann Neurol. 2015 Aug;78(2):160-77. doi: 10.1002/ana.24406. Epub 2015 Apr 9.

PMID:
25866151
3.

Elevated brain iron is independent from atrophy in Huntington's Disease.

Dumas EM, Versluis MJ, van den Bogaard SJ, van Osch MJ, Hart EP, van Roon-Mom WM, van Buchem MA, Webb AG, van der Grond J, Roos RA; TRACK-HD investigators.

Neuroimage. 2012 Jul 2;61(3):558-64. doi: 10.1016/j.neuroimage.2012.03.056. Epub 2012 Mar 28.

PMID:
22480728
4.

Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease.

Harris GJ, Pearlson GD, Peyser CE, Aylward EH, Roberts J, Barta PE, Chase GA, Folstein SE.

Ann Neurol. 1992 Jan;31(1):69-75.

PMID:
1531910
5.

Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.

van den Bogaard SJ, Dumas EM, Ferrarini L, Milles J, van Buchem MA, van der Grond J, Roos RA.

J Neurol Sci. 2011 Aug 15;307(1-2):60-8. doi: 10.1016/j.jns.2011.05.015. Epub 2011 May 31.

6.

Huntington's disease mouse models online: high-resolution MRI images with stereotaxic templates for computational neuroanatomy.

Sawiak SJ, Wood NI, Carpenter TA, Morton AJ.

PLoS One. 2012;7(12):e53361. doi: 10.1371/journal.pone.0053361. Epub 2012 Dec 31.

7.

Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease.

Franciosi S, Ryu JK, Shim Y, Hill A, Connolly C, Hayden MR, McLarnon JG, Leavitt BR.

Neurobiol Dis. 2012 Jan;45(1):438-49. doi: 10.1016/j.nbd.2011.09.003. Epub 2011 Sep 13.

PMID:
21946335
8.

Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.

Peinemann A, Schuller S, Pohl C, Jahn T, Weindl A, Kassubek J.

J Neurol Sci. 2005 Dec 15;239(1):11-9. Epub 2005 Sep 26.

PMID:
16185716
9.

In vivo cerebromicrovasculatural visualization using 3D DeltaR2-based microscopy of magnetic resonance angiography (3DDeltaR2-mMRA).

Lin CY, Lin MH, Cheung WM, Lin TN, Chen JH, Chang C.

Neuroimage. 2009 Apr 15;45(3):824-31. doi: 10.1016/j.neuroimage.2008.12.030. Epub 2008 Dec 29.

PMID:
19154792
10.

Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse.

Tabrizi SJ, Workman J, Hart PE, Mangiarini L, Mahal A, Bates G, Cooper JM, Schapira AH.

Ann Neurol. 2000 Jan;47(1):80-6.

PMID:
10632104
11.

Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model.

Cheng Y, Peng Q, Hou Z, Aggarwal M, Zhang J, Mori S, Ross CA, Duan W.

Neuroimage. 2011 Jun 1;56(3):1027-34. doi: 10.1016/j.neuroimage.2011.02.022. Epub 2011 Feb 12.

12.

Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry.

Sawiak SJ, Wood NI, Williams GB, Morton AJ, Carpenter TA.

Neurobiol Dis. 2009 Jan;33(1):20-7. doi: 10.1016/j.nbd.2008.09.016. Epub 2008 Oct 1.

PMID:
18930824
13.

Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance images.

Zhang J, Peng Q, Li Q, Jahanshad N, Hou Z, Jiang M, Masuda N, Langbehn DR, Miller MI, Mori S, Ross CA, Duan W.

Neuroimage. 2010 Feb 1;49(3):2340-51. doi: 10.1016/j.neuroimage.2009.10.027. Epub 2009 Oct 19.

14.

Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease.

Wolf RC, Grön G, Sambataro F, Vasic N, Wolf ND, Thomann PA, Saft C, Landwehrmeyer GB, Orth M.

J Cereb Blood Flow Metab. 2011 Sep;31(9):1908-18. doi: 10.1038/jcbfm.2011.60. Epub 2011 May 11.

15.

A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.

Hsiao HY, Chen YC, Chen HM, Tu PH, Chern Y.

Hum Mol Genet. 2013 May 1;22(9):1826-42. doi: 10.1093/hmg/ddt036. Epub 2013 Jan 30.

PMID:
23372043
16.

Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's disease.

Sawiak SJ, Wood NI, Williams GB, Morton AJ, Carpenter TA.

Neurobiol Dis. 2009 Jan;33(1):12-9. doi: 10.1016/j.nbd.2008.09.017. Epub 2008 Oct 1.

PMID:
18930823
17.

Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.

Kipps CM, Duggins AJ, Mahant N, Gomes L, Ashburner J, McCusker EA.

J Neurol Neurosurg Psychiatry. 2005 May;76(5):650-5.

18.

The structural involvement of the cingulate cortex in premanifest and early Huntington's disease.

Hobbs NZ, Pedrick AV, Say MJ, Frost C, Dar Santos R, Coleman A, Sturrock A, Craufurd D, Stout JC, Leavitt BR, Barnes J, Tabrizi SJ, Scahill RI.

Mov Disord. 2011 Aug 1;26(9):1684-90. doi: 10.1002/mds.23747. Epub 2011 May 6.

PMID:
21557312
19.

MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.

Bartzokis G, Tishler TA.

Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):821-33.

PMID:
10875443
20.

Brain structure in preclinical Huntington's disease.

Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC.

Biol Psychiatry. 2006 Jan 1;59(1):57-63. Epub 2005 Aug 22.

PMID:
16112655

Supplemental Content

Support Center